FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease–Associated TumorsJaleh Fallah, Julia A. Beaver, Erik Bloomquist et al.|Clinical Cancer Research|2022Cited by 180
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based ChemotherapyGwynn Ison, Richard Pazdur, Lynn Howie et al.|Clinical Cancer Research|2018Cited by 133
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These DrugsGwynn Ison, Richard Pazdur, Julia A. Beaver et al.|Clinical Cancer Research|2016Cited by 80